In a new job - July 1, 2014
Marja Makarow Chair of NordForsk Board
The NordForsk Board appointed Marja Makarow as new Chair of the NordForsk Board during its June meeting. Marja Makarow is the Vice President for Research of the Academy of Finland and Professor of Applied Biochemistry and Molecular Biology at the University of Helsinki. Also, she was Chief Executive of the European Science Foundation (ESF) in Strasbourg between […]
Pharma article - June 30, 2014
New report highlights pharmaceutical industry in Sweden
LIF, the trade association for the research-based pharmaceutical industry in Sweden, emphazises the pharmaceutical industry’s economic role in Sweden in a new report. The report Vinst för Sverige – Den forskande läkemedelsbranschens betydelse för samhället (Profit for Sweden – the research-based pharmaceutical industry’s importance for society) was presented on June 30 during the Almedalen Week, […]
Uncategorized - June 30, 2014
Mediracer releases measuring device for monitoring nervous system symptoms in diabetics
Oulu-based company Mediracer has released a measuring device to monitor the progress of degenerative nerve disease. According to the company, the device’s access to trial use in Japan will be confirmed in July, and thereafter it will also be taken into trial use in some Finnish hospital units. “After the results of Finnish and Japanese […]
Biotech Business - June 30, 2014
BioGaia expands with new production facility
BioGaia’s subsidiary TwoPac is setting up another production unit in Eslöv, in the south of Sweden. TwoPac AB was founded in 2002 to develop and manufacture packaging solutions for probiotics and is since June 2013 entirely owned by BioGaia. TwoPac mainly produces drops and straws with probiotics. During 2012 a new factory was built in […]
Intellectual Property - June 27, 2014
Orexo commences patent infringement litigation against Actavis
Orexo has filed a patent infringement action in the US District Court for the District of Delaware, against Actavis Elizabeth LLC and its parent company Actavis. The lawsuit was filed in response to an Abbreviated New Drug Application (“ANDA”) filed by Actavis. In its application, Actavis seeks to market and sell generic versions of Orexo’s patented […]
Science Award - June 27, 2014
Emmanuelle Charpentier receives Dr. Paul Janssen Award for Biomedical Research
Emmanuelle Charpentier is group leader at MIMS and guest professor at Umeå Centre for Microbial Research at Umeå University. She and the other laureate Jennifer Doudna, from the University of California, Berkeley, are recognized for their work demonstrating that Cas9 – an enzyme specialized for cutting DNA – can be programmed with single RNA molecules, […]
